Article Text

Download PDFPDF

Chlortenoxicam pharmacokinetics in young and elderly human volunteers.
  1. S. I. Ankier,
  2. A. E. Brimelow,
  3. P. Crome,
  4. A. Johnston,
  5. S. J. Warrington,
  6. P. Turner,
  7. H. P. Ferber
  1. Charterhouse Clinical Research Unit Ltd., Boundary House, London.


    The pharmacokinetics of chlortenoxicam, a new non-steroidal anti-inflammatory drug, have been compared in young and elderly healthy human volunteers. Chlortenoxicam was found to have a relatively short mean elimination half-life of about 4 hours, with considerable inter-subject variability, but there was no significant difference between young and elderly subjects. There was no evidence of accumulation with repeated administration. No unchanged chlortenoxicam was found in urine from any subject, suggesting that it undergoes extensive metabolism in man.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.